4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001209191-22-033730
Chairman and CEO bought 7,000 shares at an average $0.49 ($3,450)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Niihara Yutaka Chairman and CEO | 2022-05-20 | Purchase | +5,000 | $0.49 | $2,450 | 11,331,857 | D |
| Niihara Yutaka Chairman and CEO | 2022-05-23 | Purchase | +2,000 | $0.50 | $1,000 | 11,333,857 | D |
| Open-market purchases · 7,000 sh · avg $0.49 · $3,450 | |||||||
Loading xslF345X03/doc4.xml…